Dienogest; Estradiol Valerate Patent Expiration
Dienogest; Estradiol Valerate is Used for preventing pregnancy and treating heavy menstrual bleeding in women who use oral contraceptives. It was first introduced by Bayer Healthcare Pharmaceuticals Inc
Dienogest; Estradiol Valerate Patents
Given below is the list of patents protecting Dienogest; Estradiol Valerate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Natazia | US6133251 | Combination compound for contraception based on natural estrogen |
Oct 25, 2016
(Expired) | Bayer Hlthcare |
| Natazia | US6884793 | Combination preparation for contraception based on natural estrogens |
Oct 25, 2016
(Expired) | Bayer Hlthcare |
| Natazia | US8071577 | Multi-phase contraceptive preparation based on a natural estrogen | May 13, 2026 | Bayer Hlthcare |
| Natazia | US8153616 | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same | Jan 30, 2028 | Bayer Hlthcare |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Dienogest; Estradiol Valerate Generics
Only one generic application has been filed for Dienogest; Estradiol Valerate.
Given below is the list of companies who have filed for Dienogest; Estradiol Valerate generic.
1. WATSON LABS INC
Watson Laboratories Inc has filed for 1 generic for Dienogest; Estradiol Valerate. This n/a,2mg,3mg,n/a,n/a;3mg,2mg,2mg,1mg,n/a version comes by the name ESTRADIOL VALERATE AND DIENOGEST. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| N/A,2MG,3MG,N/A,N/A; 3MG,2MG,2MG,1MG,N/A | tablet | Prescription | ORAL | AB | May 6, 2016 |